Silo pharma produces spu-21 liposomes for rheumatoid arthritis study

Spu-21 has shown anti-arthritic activity for therapeutic use in preclinical studies. spu-21 has shown anti-arthritic activity for therapeutic use in preclinical studies.

SILO Ratings Summary

SILO Quant Ranking